News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,038 Results
Type
Article (8017)
Company Profile (142)
Press Release (478879)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166741)
Career Advice (304)
Deals (25740)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238194)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (492)
Accelerated approval (27)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33142)
ALS (115)
Alzheimer's disease (989)
Antibody-drug conjugate (ADC) (300)
Approvals (10428)
Artificial intelligence (348)
ASCO (160)
Autoimmune disease (230)
Automation (32)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6952)
BIO (36)
Biologics (22)
BIOSECURE Act (1)
Biosimilars (120)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (6)
Bladder cancer (140)
Brain cancer (34)
Breast cancer (527)
Cancer (3871)
Cardiovascular disease (232)
Career advice (242)
Career pathing (1)
CAR-T (183)
CDC (1)
CDMO (25)
Celiac Disease (1)
Cell therapy (500)
Cervical cancer (35)
Clinical research (48166)
Collaboration (1323)
Commercialization (16)
Compensation (1589)
Complete response letters (35)
COVID-19 (761)
CRISPR (66)
C-suite (834)
Cystic fibrosis (88)
Data (6090)
Denatured (4)
Depression (108)
Dermatology (87)
Diabetes (372)
Diagnostics (4236)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (167)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (172)
Earnings (73796)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88358)
Executive appointments (723)
Eye disease (2)
FDA (12579)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (983)
Gene editing (129)
Generative AI (11)
Gene therapy (341)
GLP-1 (302)
Government (944)
Grass and pollen (2)
Guidances (281)
Healthcare (9366)
Hematology (94)
HIV (55)
Huntington's disease (24)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (72)
Immunology and inflammation (111)
Immuno-oncology (64)
Indications (171)
Infectious disease (957)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (86)
Intellectual property (268)
Interviews (41)
IPO (12394)
IRA (2)
Job creations (1967)
Job search strategy (232)
JPM (1)
Kidney cancer (17)
Kidney disease (61)
Layoffs (59)
Legal (5194)
Licensing (29)
Liver cancer (46)
Longevity (21)
Lung cancer (560)
Lung diease (8)
Lymphoma (263)
Machine learning (29)
Management (3)
Manufacturing (595)
Marketing (12)
MASH (120)
Medical affairs (2)
Medical device (8693)
Medtech (8862)
Mergers & acquisitions (14433)
Metabolic disorders (750)
mRNA (70)
Multiple sclerosis (109)
Multispecific (1)
NASH (4)
Netherlands (1)
Neurodegenerative disease (235)
Neuropsychiatric disorders (40)
Neuroscience (1907)
Neurotech (1)
NextGen: Class of 2026 (3147)
Non-profit (843)
Obesity (235)
Opinion (10)
Ovarian cancer (173)
Pain (183)
Pancreatic cancer (219)
Parkinson's disease (214)
Partnered (12)
Patents (517)
Patient advocacy (1)
Patient recruitment (540)
Patient selection (24)
Peanut (33)
People (41438)
Peptides (11)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15560)
Phase 2 (21522)
Phase 3 (14507)
Pipeline (8059)
Policy (18)
Postmarket research (1559)
Preclinical (6568)
Press Release (34)
Prostate cancer (199)
Psychedelics (10)
Radiopharmaceuticals (199)
Rare diseases (609)
Real estate (3023)
Recruiting (6)
Regenerative medicine (8)
Regulatory (15070)
Reports (23)
Research institute (589)
Resumes & cover letters (45)
Rett syndrome (45)
RNA editing (8)
RSV (48)
Schizophrenia (107)
Series A (172)
Series B (125)
Service/supplier (5)
Sickle cell disease (64)
Spinal muscular atrophy (92)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (52)
Vaccines (325)
Venture capital (17)
Weight loss (76)
Wet AMD (1)
Women's health (93)
Date
Last 7 days (357)
Last 30 days (1329)
Last 365 days (19079)
2026 (14667)
2025 (19238)
2024 (22988)
2023 (26538)
2022 (34587)
2021 (37168)
2020 (33449)
2019 (23258)
2018 (17461)
2017 (18765)
2016 (17917)
2015 (24248)
2014 (21679)
2013 (18127)
2012 (20221)
2011 (20426)
2010 (20332)
Location
Africa (230)
Alabama (80)
Alaska (2)
Arizona (315)
Arkansas (12)
Asia (18007)
Australia (2114)
California (12629)
Canada (3315)
China (560)
Colorado (512)
Connecticut (439)
Delaware (219)
Europe (24746)
Florida (1903)
Georgia (400)
Hawaii (3)
Idaho (46)
Illinois (751)
India (56)
Indiana (328)
Iowa (17)
Japan (442)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1252)
Massachusetts (8264)
Michigan (317)
Minnesota (585)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (127)
New Hampshire (60)
New Jersey (2771)
New Mexico (12)
New York (2964)
North Carolina (1339)
North Dakota (4)
Northern California (6375)
Ohio (300)
Oklahoma (14)
Oregon (16)
Pennsylvania (2346)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (79)
South Dakota (1)
Southern California (5259)
Tennessee (126)
Texas (2078)
United States (40937)
Utah (384)
Vermont (1)
Virginia (161)
Washington D.C. (39)
Washington State (975)
West Virginia (1)
Wisconsin (80)
Wyoming (1)
487,038 Results for "vapotherm inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients
April 22, 2026
·
2 min read
Business
Vapotherm Reports First Quarter 2024 Financial Results
Vapotherm, Inc., announced first quarter 2024 financial results and related highlights.
May 9, 2024
·
17 min read
Business
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Vapotherm, Inc. (OTCQX: VAPO), (“Vapotherm” or the “Company”), today announced fourth quarter and fiscal year 2023 financial results and related highlights.
February 22, 2024
·
25 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Genetown
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE
Vapotherm, Inc., announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.
March 15, 2024
·
4 min read
Business
Vapotherm Reports Third Quarter 2023 Financial Results
Vapotherm, Inc., announced third quarter 2023 financial results and related highlights.
November 8, 2023
·
23 min read
Business
Vapotherm Reports Second Quarter 2023 Financial Results
Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced second quarter 2023 financial results.
August 8, 2023
·
23 min read
Deals
Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private
Vapotherm, Inc., announced that it has signed a definitive merger agreement with a newly-formed entity organized and funded by an affiliate of Perceptive Advisors, LLC, a leading health care investment firm, and its Perceptive Discovery Fund.
June 17, 2024
·
9 min read
Business
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)
Onymos, developer of the world’s first Features-as-a-Service platform, and Vapotherm, Inc. (OTCQX: VAPO), (“Vapotherm”), a global medical technology company whose proprietary high-velocity therapy® products treat patients of all ages suffering from respiratory distress, today announced the formation of a development and commercialization partnership.
March 20, 2024
·
4 min read
Business
Vapotherm To Report Third Quarter 2023 Financial Results
Vapotherm, Inc., announced that it will release financial results for the third quarter of 2023 after the close of trading on Wednesday, November 8, 2023.
November 1, 2023
·
2 min read
1 of 48,704
Next
